Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 36 citing articles:

Gut Microbiota Participates in Polystyrene Microplastics-Induced Hepatic Injuries by Modulating the Gut–Liver Axis
Kai-Kai Zhang, Jian-Zheng Yang, Lijian Chen, et al.
ACS Nano (2023) Vol. 17, Iss. 15, pp. 15125-15145
Closed Access | Times Cited: 83
Mechanistic insights of soluble uric acid-induced insulin resistance: Insulin signaling and beyond
Wei Yu, De Xie, Tetsuya Yamamoto, et al.
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 2, pp. 327-343
Closed Access | Times Cited: 27
Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation
Yan Zhang, Xueying Zhang, Shan-Rui Shi, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 11
Protoberberine alkaloids: A review of the gastroprotective effects, pharmacokinetics, and toxicity
Zedong Xiang, Huida Guan, Xiang Zhao, et al.
Phytomedicine (2024) Vol. 126, pp. 155444-155444
Closed Access | Times Cited: 9
Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective
Yansong Fu, Zhipeng Wang, Hong Qin
Metabolites (2024) Vol. 14, Iss. 4, pp. 218-218
Open Access | Times Cited: 8
Cyanidin-3-O-Glucoside Alleviates Alcoholic Liver Injury via Modulating Gut Microbiota and Metabolites in Mice
Lingfeng Zhu, Fuliang Cao, Zuomin Hu, et al.
Nutrients (2024) Vol. 16, Iss. 5, pp. 694-694
Open Access | Times Cited: 6
Unlocking the potential of Berberine: Advancing cancer therapy through chemosensitization and combination treatments
Anjana Sajeev, Bethsebie Sailo, Jyothsna Unnikrishnan, et al.
Cancer Letters (2024) Vol. 597, pp. 217019-217019
Closed Access | Times Cited: 6
Role of CD36 in central nervous system diseases
Min Feng, Qiang Zhou, Huimin Xie, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 3, pp. 512-518
Open Access | Times Cited: 14
Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease—Clinical and Pre-Clinical Overview and Systematic Review of the Literature
Florentina Ioniţă‐Radu, Cristina Patoni, Andreea Simona Nancoff, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4201-4201
Open Access | Times Cited: 5
Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD
Sa Yang, Shijie Cao, Congyu Li, et al.
Journal of Ethnopharmacology (2024) Vol. 332, pp. 118354-118354
Closed Access | Times Cited: 5
Evolving interplay between natural products and gut microbiota
Ningning Zhang, Zheng‐Meng Jiang, Shang‐Zhen Li, et al.
European Journal of Pharmacology (2023) Vol. 949, pp. 175557-175557
Closed Access | Times Cited: 12
Intestinal flora: A new target for traditional Chinese medicine to improve lipid metabolism disorders
Min Liu, Wei Shi, Yefang Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH
Melchiorre Cervello, Giuseppa Augello, Lucio Cocco, et al.
Advances in Biological Regulation (2024) Vol. 92, pp. 101032-101032
Closed Access | Times Cited: 4
Nanostructured biloalbuminosomes loaded with berberine and berberrubine for Alleviating heavy Metal-Induced male infertility in rats
Aya M. Helal, Mona M Yossef, Inas K. Seif, et al.
International Journal of Pharmaceutics (2024), pp. 124892-124892
Closed Access | Times Cited: 4
Gut microbiota-derived UDCA enhanced by metformin inhibits FXR to activate autophagy against MCD diet-induced NAFLD in mice
Xiujie Liu, Hongxia Sun, Qing Han, et al.
International Immunopharmacology (2025) Vol. 153, pp. 114471-114471
Closed Access
Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review
Yajie Cai, Qiaoning Yang, Yanqiao Yu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Modulatory effect of camel milk on intestinal microbiota of mice with non-alcoholic fatty liver disease
Shiqi Hao, Liang Ming, Yafei Li, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 15
Molecular Mechanism Pathways of Natural Compounds for the Treatment of Non-Alcoholic Fatty Liver Disease
Xiaolei Fang, Jiayu Song, Kaixuan Zhou, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5645-5645
Open Access | Times Cited: 9
Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism
Yafei Liu, Huanhuan Wang, Yin-Hong Geng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Investigation of the Therapeutic Effect of Total Alkaloids of Corydalis saxicola Bunting on CCl4-Induced Liver Fibrosis in Rats by LC/MS-Based Metabolomics Analysis and Network Pharmacology
Qianyi Wang, Zhuo Luo, Danfeng Li, et al.
Metabolites (2022) Vol. 13, Iss. 1, pp. 9-9
Open Access | Times Cited: 12
Differences in Metabolite Profiles of Dihydroberberine and Micellar Berberine in Caco-2 Cells and Humans—A Pilot Study
Chuck Chang, Yoon Seok Roh, Min Du, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5625-5625
Open Access | Times Cited: 2
Gut microbiota: The key to the treatment of metabolic syndrome in traditional Chinese medicine – a case study of diabetes and nonalcoholic fatty liver disease
Bao Yang, Xiao Han, Da Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Phytochemical analysis and in vitro and in vivo antioxidant properties of Plagiorhegma dubia Maxim as a medicinal crop for diabetes treatment
Hui Sun, Meihua Chen, Xu He, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 6, pp. 104788-104788
Open Access | Times Cited: 6
Berberine-microbiota interplay: orchestrating gut health through modulation of the gut microbiota and metabolic transformation into bioactive metabolites
Tessa Dehau, Marc Cherlet, Siska Croubels, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Zuogui Jiangtang Shuxin formula Ameliorates diabetic cardiomyopathy mice via modulating gut-heart axis
Yalan Huang, Xiang Qin, Jun-ju Zou, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top